Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial.

Charles W. Abbottsmith, Eugene S. Chung, Thomas Varricchione, Paul Andre de Lame, Marc A. Silver, Gary S. Francis, Arthur M. Feldman

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

The Prospective Evaluation of Enhanced External Counterpulsation in Congestive Heart Failure (PEECH) trial demonstrated that enhanced external counterpulsation (EECP) therapy increased exercise duration and improved functional status and quality of life without affecting peak oxygen consumption. The authors present data from a prespecified subgroup of elderly patients (65 years or older) enrolled in the PEECH trial. The 2 co-primary end points were the percentage of subjects with a >60-second increase in exercise duration and the percentage of subjects with a >1.25-mL/kg/min increase in peak volume of oxygen consumption. At 6-month follow-up, the exercise responder rate was significantly higher in EECP patients compared with controls (P=.008). Further, in contrast to the overall PEECH study, the EECP group demonstrated a significantly higher responder rate for peak oxygen consumption (P=.017). The authors conclude that an older subgroup of PEECH subjects confirms the beneficial effect of EECP in patients with chronic, stable, mild-to-moderate heart failure.

Original languageEnglish (US)
Pages (from-to)307-311
Number of pages5
JournalCongestive heart failure (Greenwich, Conn.)
Volume12
Issue number6
DOIs
StatePublished - 2006

Fingerprint Dive into the research topics of 'Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial.'. Together they form a unique fingerprint.

Cite this